Search - tctmd.com

Displaying 1 - 20 of 174

Sort: Relevancy | Date

Presentation TCT 2025

TCT 1228: Impact of Downsizing on Evolut Transcatheter Valve Leaflet Positioning During Valve-in-Valve: A Bench Study

Presenter: Colin Jamieson

October 27, 2025

Presentation TCT 2025

TCT 1222: Bioprosthetic Valve Fracture During VIV TAVR with a Self-Expanding Evolut Valve: Safety and Hemodynamics Outcomes from the Transcatheter Valve Therapy Registry

Presenter: Keith B. Allen

October 26, 2025

Presentation TCT 2025

Retrograde Techniques for CTO PCI: An Evolution in Balancing Risk and Reward

Presenter: Stephane Rinfret

October 26, 2025

Presentation TCT 2025

A New FDA for a New Era: Innovation Demands Evolution!

Presenter: Michael R. Jaff

October 25, 2025

Presentation TCT 2025

TCT 869: Comparison of Evolut FX With Latest-Generation Evolut FX+ Transcatheter Aortic Valve Systems in Real-World Practice

Presenter: Guilherme Attizzani

October 25, 2025

Presentation TCT 2025

TCT 726: Coronary Obstruction Following Transcatheter Aortic Valve Replacement Using CoreValve or Evolut in Native Aortic Stenosis: A Systematic Review

Presenter: Aoi Omori

October 25, 2025

Presentation TCT 2025

TCT 2: Win Ratio Analysis of 1-Year Outcomes in the LANDMARK Trial: Myval vs Contemporary THVs (Sapien or Evolut) in Patients with Symptomatic Severe Aortic Stenosis

Presenter: Akihiro Tobe

October 25, 2025

News Conference News TCT 2024

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

L.A. McKeown

November 01, 2024

News Conference News TCT 2024

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

Todd Neale

October 30, 2024

Presentation TCT 2024

AS in Women

Presenter: Renuka Jain

October 29, 2024

Presentation TCT 2024

Case Background and Valve Selection Discussion

Presenter: Bruce Rutkin

October 29, 2024

Presentation TCT 2024

Case Outcome

Presenter: Bruce Rutkin

October 29, 2024

Presentation TCT 2024

The Evolution of Transcatheter Mitral Valve Repair: Technical and Procedural Insights from an Early Human Feasibility Program (Case-Based)

Presenter: Alexandre Abizaid

October 29, 2024

Presentation TCT 2024

Evolution of PCI – Role and Value of Drug-Eluting Balloons

Presenter: Roxana Mehran

October 29, 2024

Presentation TCT 2024

TCT 337: Evolution of Untreated Moderate Mitral Regurgitation After Transcatheter Aortic Valve Implantation

Presenter: Massimo Baudo

October 28, 2024

Presentation TCT 2024

TCT 933: Win Ratio Analysis of LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis

Presenter: Patrick Serruys

October 28, 2024

Presentation TCT 2024

TCT 165: Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry

Presenter: Anthony Matta

October 28, 2024

News Conference News TCT 2024

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

Michael O'Riordan

October 27, 2024

Presentation TCT 2024

TCT 1459: Valve-in-Valve With High Risk of Double Coronary Obstruction in a Degenerated Self Expandable Evolut R TAVR

Presenter: Hector Alvarez Covarrubias

October 27, 2024

Presentation TCT 2024

TCT 1566: TAVR-in-TAVR of Sapien in Evolut

Presenter: Daniel Zumerkorn Hassan

October 27, 2024

Advertisement

TCT 1228: Impact of Downsizing on Evolut Transcatheter Valve Leaflet Positioning During Valve-in-Valve: A Bench Study

TCT 1222: Bioprosthetic Valve Fracture During VIV TAVR with a Self-Expanding Evolut Valve: Safety and Hemodynamics Outcomes from the Transcatheter Valve Therapy Registry

Retrograde Techniques for CTO PCI: An Evolution in Balancing Risk and Reward

A New FDA for a New Era: Innovation Demands Evolution!

TCT 869: Comparison of Evolut FX With Latest-Generation Evolut FX+ Transcatheter Aortic Valve Systems in Real-World Practice

TCT 726: Coronary Obstruction Following Transcatheter Aortic Valve Replacement Using CoreValve or Evolut in Native Aortic Stenosis: A Systematic Review

TCT 2: Win Ratio Analysis of 1-Year Outcomes in the LANDMARK Trial: Myval vs Contemporary THVs (Sapien or Evolut) in Patients with Symptomatic Severe Aortic Stenosis

Pooled All-Female Analysis Support Benefits of TAVI Over SAVR

ACURATE IDE Trial Misses Primary Endpoint in All-Risk TAVI Patients

AS in Women

Case Background and Valve Selection Discussion

Case Outcome

The Evolution of Transcatheter Mitral Valve Repair: Technical and Procedural Insights from an Early Human Feasibility Program (Case-Based)

Evolution of PCI – Role and Value of Drug-Eluting Balloons

TCT 337: Evolution of Untreated Moderate Mitral Regurgitation After Transcatheter Aortic Valve Implantation

TCT 933: Win Ratio Analysis of LANDMARK Trial: Myval Transcatheter Heart Valve vs Contemporary Standard Valves (Sapien and Evolut) in Patients With Severe Aortic Stenosis

TCT 165: Comparison of Paravalvular Leak in SAPIEN 3 and EVOLUT PRO Valves in Transcatheter Aortic Valve Replacement: A Multicenter Registry

Protecting Coronary Access After TAVI: Valve Choice Clues From CAVEAT

TCT 1459: Valve-in-Valve With High Risk of Double Coronary Obstruction in a Degenerated Self Expandable Evolut R TAVR

TCT 1566: TAVR-in-TAVR of Sapien in Evolut

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content